Transcultural diabetes nutrition algorithm: a malaysian application
Zanariah Hussein1, Osama Hamdy2, Yook Chin Chia3
1Department of Medicine, Hospital Putrajaya, Pusat Pentadbiran Kerajaan Persekutuan, Presint 7, 62250 Putrajaya, Malaysia.
International Journal of Endocrinology
|January 4, 2014
Summary
Poor glycemic control in Malaysia necessitates tailored nutrition strategies. This study adapts the transcultural Diabetes Nutrition Algorithm (tDNA) for Malaysian patients with prediabetes and type 2 diabetes mellitus (T2D).
Area of Science:
- Endocrinology
- Nutrition Science
- Public Health
Background:
- Glycemic control in Malaysian patients with prediabetes and type 2 diabetes mellitus (T2D) is suboptimal and has worsened over the last decade.
- Medical Nutrition Therapy (MNT) is crucial for improving glycemic control.
- International diabetes nutrition guidelines may not be fully applicable to Malaysian patients due to unique cultural, lifestyle, and genetic factors.
Purpose of the Study:
- To report the Malaysian adaptation of the transcultural Diabetes Nutrition Algorithm (tDNA).
- To develop culturally relevant nutritional management recommendations for prediabetes and T2D in Malaysia.
Main Methods:
- Restructuring of international evidence-based guidelines for nutritional management of prediabetes and T2D.
- Development of a global tDNA template designed for simplicity, flexibility, and cultural modification.
- Adaptation of the tDNA template to incorporate Malaysia-specific epidemiologic, physiologic, cultural, and lifestyle factors, and local guideline recommendations.
Main Results:
- The Malaysian adaptation of the tDNA accounts for unique local factors.
- The adapted tDNA provides a framework for culturally sensitive nutritional management.
- This adaptation aims to improve the applicability and implementation of MNT in Malaysia.
Conclusions:
- The Malaysian tDNA offers a culturally tailored approach to nutritional management for prediabetes and T2D.
- This adaptation addresses the limitations of international guidelines in the Malaysian context.
- Implementation of the Malaysian tDNA is expected to enhance glycemic control in the local population.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25

